Evidence map›Paper›PMID 38285801›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2024

Classification and Diagnostic Prediction of Colorectal Cancer Mortality Based on Machine Learning Algorithms: A Multicenter National Study.

Gohar Mohammadi, Mehdi Azizmohammad Looha, Mohammad Amin Pourhoseingholi, Mostafa Rezaei Tavirani, Samaneh Sohrabi, Amirali Zareie Shab Khaneh, Hassan Piri, Maryam Alaei, Naser Parvani, Iman Vakilzadeh and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Gohar MohammadiCancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9512-5652
Mehdi Azizmohammad LoohaBasic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-0700-1431
Mohammad Amin PourhoseingholiGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mostafa Rezaei TaviraniProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Samaneh SohrabiVice Chancellor in Administration and Resources Development Affairs, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-8049-0307
Amirali Zareie Shab KhanehDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Hassan PiriShahid Beheshti University of Medical Sciences, Tehran, Iran.
Maryam AlaeiCardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6564-7863
Naser ParvaniVice Chancellor in Administration and Resources Development Affairs, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-2877-1379
Iman VakilzadehVice Chancellor in Administration and Resources Development Affairs, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5123-6035
Sara JavadiVice Chancellor for Research & Technology, Shiraz University of Medical Sciences, Shiraz, Iran.
Zeynab Moradian Haft CheshmehDepartment of Epidemiology, Faculty of Health, Iran University of Medical Science,Tehran, Iran.ORCID 0000-0002-1155-9104
Zahra RazzaghiLaser Application in Medical Sciences Research Center. Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Reza Mahmoud RobatiDepartment of Dermatology, Director of Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mona Zamanian AzodiProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saba Zarean ShahrakiDepartment of Health Information Technology and Management, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Melika HadaviDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences.
Raheleh TalebiDepartment of Mathematics at Architecture and Computer Engineering, University of Applied Sciences (unit 10), Tehran, Iran.
Jamshid Charati YazdaniHealth Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad Esmaeil MotlaghDepartment of Pediatrics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Soheila KhodakarimDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5473-999X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal cancer (CRC) ranks as the second leading cause of cancer-related deaths. This study aimed to predict survival outcomes of CRC patients using machine learning (ML) methods. MATERIAL AND

methodsA retrospective analysis included 1853 CRC patients admitted to three prominent tertiary hospitals in Iran from October 2006 to July 2019. Six ML methods, namely logistic regression (LR), Naïve Bayes (NB), Support Vector Machine (SVM), Neural Network (NN), Decision Tree (DT), and Light Gradient Boosting Machine (LGBM), were developed with 10-fold cross-validation. Feature selection employed the Random Forest method based on mean decrease GINI criteria. Model performance was assessed using Area Under the Curve (AUC).

resultsTime from diagnosis, age, tumor size, metastatic status, lymph node involvement, and treatment type emerged as crucial predictors of survival based on mean decrease GINI. The NB (AUC = 0.70, 95% Confidence Interval [CI] 0.65-0.75) and LGBM (AUC = 0.70, 95% CI 0.65-0.75) models achieved the highest predictive AUC values for CRC patient survival.

conclusionsThis study highlights the significance of variables including time from diagnosis, age, tumor size, metastatic status, lymph node involvement, and treatment type in predicting CRC survival. The NB model exhibited optimal efficacy in mortality prediction, maintaining a balanced sensitivity and specificity. Policy recommendations encompass early diagnosis and treatment initiation for CRC patients, improved data collection through digital health records and standardized protocols, support for predictive analytics integration in clinical decisions, and the inclusion of identified prognostic variables in treatment guidelines to enhance patient outcomes.

Indexed as

AlgorithmsColorectal NeoplasmsBayes TheoremHumansMachine LearningRetrospective Studiescolorectal cancerData miningFeature selectionMachine Learning Algorithmsmortality prediction

Identifiers

PMID38285801
PMCPMC10911721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.